This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. E. NORRIS, M.D.; HUGH H. HANSON, M.D.; R. KENNETH LOEFFLER, M.D.

AMA Arch Intern Med. 1956;98(3):356-364.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SINCE Cooley and Lee's description of Mediterranean anemia, in 1925, a voluminous literature has accumulated on the subject. This disease entity, because of its variable manifestations, has been described and discussed under several names— Cooley's anemia, erythroblastic anemia, thalassemia, Mediterranean hemolytic disease, Mediterranean anemia, and Mediterranean hemopathic syndrome. This constitutional hereditary defect in hemopoiesis is manifest clinically as a disease whose severity may vary from exhibiting only characteristic abnormalities of the erythrocytes to being a severe anemia with hepatosplenomegaly, leg ulcers, and bone changes, with fatal termination in infancy or early childhood. The erythocytes characteristically show anisocytosis, poikilocytosis, leptocytosis, and increased resistance to hypotonic saline, with the presence of many target cells. Although this disease occurs usually in persons of Mediterranean extraction, well-documented examples of its occurrence in persons of Indian, Chinese. African, and pure English stock have been reported. Despite the variable clinical manifestations and varied racial incidence of . . . [Full Text PDF of this Article]

Author Affiliations
Houston, Texas

Herrmann Hospital and Baylor University College of Medicine.

Footnotes
Submitted for publication Feb. 4, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?